Skip to main content

FG Annuities Life Inc

For the period ended Dec 31, 2023. Filed Feb 29, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 29, 2024

FG$25.55+9.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Signatures

Pursuant to the requirements of section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

F&G Annuities & Life, Inc. (Registrant)
Date:February 29, 2024By:/s/ Wendy J.B. Young
Chief Financial Officer
(on behalf of the Registrant and as Principal Financial Officer)

POWERS OF ATTORNEY

KNOW ALL BY THESE PRESENT, that each person whose signature appears below constitutes and appoints Christopher O. Blunt and Wendy J.B. Young, and each of them, acting individually, as his true and lawful attorney-in-fact and agent, each with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite or necessary to be done in and about the premises, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated

SignatureTitleDate
/s/ Christopher O. BluntDirector, President and Chief Executive OfficerFebruary 29, 2024
Christopher O. Blunt(Principal Executive Officer)
/s/ Wendy J.B. YoungChief Financial OfficerFebruary 29, 2024
Wendy JB Young(Principal Financial and Accounting Officer)
/s/ William P. Foley, IIDirector and Executive Chairman of the BoardFebruary 29, 2024
William P. Foley, II
/s/ Douglas K. AmmermanDirectorFebruary 29, 2024
Douglas K. Ammerman
/s/ Celina J. Wang DokaDirectorFebruary 29, 2024
Celina Wang Doka
/s/ Douglas MartinezDirectorFebruary 29, 2024
Douglas Martinez
/s/ Michael J. NolanDirectorFebruary 29, 2024
Michael J. Nolan
/s/ Raymond R. QuirkDirectorFebruary 29, 2024
Raymond R. Quirk
/s/ John D. RoodDirectorFebruary 29, 2024
John D. Rood

Schedule I

SUMMARY OF INVESTMENTS - OTHER THAN INVESTMENTS IN RELATED PARTIES

(In millions)Amortized CostFair ValueAmount Shown on Consolidated Balance Sheet
Fixed maturity securities, available for sale:
United States Government full faith and credit$258$261$261
United States Government sponsored entities343131
United States municipalities, states and territories1,7761,5671,567
Foreign Governments263226226
Corporate securities:
Finance, insurance and real estate7,5266,8956,895
Manufacturing, construction and mining1,077947947
Utilities, energy and related sectors2,8252,3742,374
Wholesale/retail trade2,7992,4332,433
Services, media and other4,5533,9303,930
Hybrid securities668618618
Non-agency residential mortgage-backed securities2,4672,3932,393
Commercial mortgage-backed securities4,7324,4104,410
Asset-backed securities9,2738,9298,929
CLO securities5,3505,4055,405
Total fixed maturity securities, available for sale$43,601$40,419$40,419
Equity securities682606606
Limited partnerships:
Private equity1,2771,2771,277
Real assets465463463
Credit1,0391,0391,039
Limited partnerships2,7812,7792,779
Commercial mortgage loans2,5382,2532,538
Residential mortgage loans2,7982,5452,798
Other (primarily derivatives and company owned life insurance)1,6211,6971,697
Short term investments1,4521,4521,452
Total investments$55,473$51,751$52,289

See Report of Independent Registered Public Accounting Firm

Schedule II

SUPPLEMENTAL CONDENSED BALANCE SHEET

(In millions)December 31, 2023December 31, 2022
Assets
Investments in consolidated subsidiaries$4,236$2,806
Fixed maturity securities, available for sale5454
Cash and cash equivalents1252
Prepaid expenses and other assets36
Income taxes receivable1360
Total assets$4,318$2,978
Liabilities and Equity
Accounts payable and other liabilities2024
Intercompany payables13
Notes payable1,194546
Total liabilities$1,215$573
Equity:
F&G common stock, $0.001 par value; authorized 500,000,000 shares as of December 31, 2023 and 2022; outstanding of 126,332,142 and 126,409,904 as of December 31, 2023 and 2022, respectively, and issued of 127,234,902 and 126,409,904 as of December 31, 2023 and 2022, respectively——
Additional paid-in-capital3,1853,162
Retained earnings1,9262,061
Accumulated other comprehensive earnings (loss)(1,990)(2,818)
Treasury stock, at cost (902,760 shares and 7,762 shares as of December 31, 2023 and2022, respectively)(18)—
Total equity3,1032,405
Total liabilities and equity$4,318$2,978

Schedule II (continued)

SUPPLEMENTAL CONDENSED INCOME STATEMENT

(In millions)Year ended December 31,
202320222021
Revenues:
Life insurance premiums and other fees$3$—$—
Interest and investment income163—
Total revenues193—
Expenses:
Other operating expenses5——
Interest expense7573
Total expenses8073
Earnings (loss) before income tax expense and equity in earnings of subsidiaries(61)(4)(3)
Income tax expense (benefit)(13)(24)—
Earnings (loss) before equity in earnings of subsidiaries(48)20(3)
Equity in earnings (loss) of subsidiaries(10)6151,243
Net earnings (loss)$(58)$635$1,240

Schedule II (continued)

SUPPLEMENTAL CONDENSED CASH FLOW STATEMENT

(In millions)Year ended December 31,
202320222021
Cash flows from operating activities:
Net earnings (loss)$(58)$635$1,240
Adjustments to reconcile net earnings to net cash (used in) provided by operating activities:
Gain on sales of investments—1—
Equity in earnings (loss) of subsidiaries10(615)(1,243)
Net change in income taxes47(25)—
Stock-based compensation23129
Net (increase) decrease in other assets and other liabilities(28)(9)(3)
Net cash provided by (used in) operating activities(6)(1)3
Cash flows from investing activities:
Proceeds from sales, calls and maturities of investment securities24—
Net cash provided by (used in) investing activities24—
Cash flows from financing activities:
Borrowings845550—
Debt issuance costs(12)(4)—
Capital contributions(589)(500)—
Purchases of treasury stock(18)——
Dividends paid(77)——
Net revolving credit facility repayments(185)——
Net cash provided by (used in) financing activities(36)46—
Net change in cash and cash equivalents(40)493
Cash and cash equivalents at beginning of year523—
Cash and cash equivalents at end of year$12$52$3

Schedule III

SUPPLEMENTARY INSURANCE INFORMATION

(In millions)Year ended December 31,
202320222021
Deferred acquisition costs$2,215$1,411$784
Future policy benefits, losses, claims and loss expenses7,0505,0214,918
Other policy claims and benefits payable92109109
Life insurance premiums and other fees2,4131,7041,407
Interest and investment income2,2111,6551,852
Benefits, claims, losses and settlement expenses(3,553)(1,126)(1,932)
Amortization of deferred policy acquisition costs(191)(99)(46)
Other operating expenses, net of deferrals(146)(102)(105)

Schedule IV

SUPPLEMENTAL REINSURANCE SCHEDULE

For the year ended December 31, 2023Gross AmountCeded to other companiesAssumed from other companiesNet AmountPercentage of amount assumed to net
Life insurance in force$8,448$(1,436)$—$7,012—%
Premiums and other considerations:
Traditional life insurance premiums148(105)—43—%
Life-contingent PRT premiums1,964——1,964—%
Annuity product charges and other fees455(49)—406—%
Total premiums and other considerations$2,567$(154)$—$2,413—%
For the year ended December 31, 2022Gross AmountCeded to other companiesAssumed from other companiesNet AmountPercentage of amount assumed to net
Life insurance in force$6,296$(1,524)$—$4,772—%
Premiums and other considerations:
Traditional life insurance premiums160(128)—32—%
Life-contingent PRT premiums1,362——1,362—%
Annuity product charges and other fees360(50)—310—%
Total premiums and other considerations$1,882$(178)$—$1,704—%
For the year ended December 31, 2021Gross AmountCeded to other companiesAssumed from other companiesNet AmountPercentage of amount assumed to net
Life insurance in force$4,895$(1,642)$—$3,253—%
Premiums and other considerations:
Traditional life insurance premiums168(137)—31—%
Life-contingent PRT premiums1,146——1,146—%
Annuity product charges and other fees281(51)—230—%
Total premiums and other considerations$1,595$(188)$—$1,407—%
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.